Intermittent Antimalaria Treatment With SP in African Children
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00168948
Verified February 2003 by Charite University, Berlin, Germany. Recruitment status was: Active, not recruiting
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
2 Months to 4 Months (Child)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
informed consent by parents or guardian
no concomitant serious disease
age >2 months
serious allergy or hypersensitivity to sulfonamides or pyrimethamine